When does Abbott Laboratories (ABT) report earnings? Before the open in 12 of its last 12 reports
Of its last 12 earnings announcements: 12 before the open. Each one comes from the 8-K with item 2.02 that Abbott Laboratories filed with the SEC, paired with the 10-Q or 10-K for that same quarter: 67 quarters since Jul 15, 2009, and every row links to its filing.
Next date: the one ABT had announced, Oct 21, 2026, has already happened and its 8-K is filed (below). There is no further date yet inside the calendar this site covers (Oct 21, 2026 to Nov 24, 2026).
The latest, still without a report
- Oct 21, 2026, Wednesday at 07:36 New York time (before the open). see the 8-K
- Jul 16, 2026, Thursday at 07:36 New York time (before the open). see the 8-K
They are this company's most recent 8-K filings with item 2.02 and they do not yet have their 10-Q or 10-K behind them, so there is no way to say which quarter they belong to: they do not enter the figures above or the table, and for the same reason one of them might not be an earnings announcement at all (some companies use this same item for production figures or monthly sales).
The last 20 quarters, one by one
"Lead": trading sessions between the announcement and the full quarterly report to the SEC (10-Q, or 10-K at fiscal year end). For Abbott Laboratories, a median of 10 sessions over the last 12 quarters.
| Announcement | Day | Time (NY) | Session | Quarter ended | SEC report | Lead | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Thursday | 07:36 | before the open | Mar 31, 2026 | 10-Q · Apr 29, 2026 | 9 sessions | 8-K |
| Jan 22, 2026 | Thursday | 07:35 | before the open | Dec 31, 2025 | 10-K · Feb 20, 2026 | 20 sessions | 8-K |
| Oct 15, 2025 | Wednesday | 07:33 | before the open | Sep 30, 2025 | 10-Q · Oct 29, 2025 | 10 sessions | 8-K |
| Jul 17, 2025 | Thursday | 07:34 | before the open | Jun 30, 2025 | 10-Q · Jul 30, 2025 | 9 sessions | 8-K |
| Apr 16, 2025 | Wednesday | 07:36 | before the open | Mar 31, 2025 | 10-Q · Apr 30, 2025 | 9 sessions | 8-K |
| Jan 22, 2025 | Wednesday | 07:13 | before the open | Dec 31, 2024 | 10-K · Feb 21, 2025 | 21 sessions | 8-K |
| Oct 16, 2024 | Wednesday | 07:37 | before the open | Sep 30, 2024 | 10-Q · Oct 31, 2024 | 11 sessions | 8-K |
| Jul 18, 2024 | Thursday | 07:37 | before the open | Jun 30, 2024 | 10-Q · Jul 31, 2024 | 9 sessions | 8-K |
| Apr 17, 2024 | Wednesday | 07:36 | before the open | Mar 31, 2024 | 10-Q · May 2, 2024 | 11 sessions | 8-K |
| Jan 24, 2024 | Wednesday | 07:36 | before the open | Dec 31, 2023 | 10-K · Feb 16, 2024 | 17 sessions | 8-K |
| Oct 18, 2023 | Wednesday | 07:37 | before the open | Sep 30, 2023 | 10-Q · Nov 1, 2023 | 10 sessions | 8-K |
| Jul 20, 2023 | Thursday | 08:29 | before the open | Jun 30, 2023 | 10-Q · Aug 3, 2023 | 10 sessions | 8-K |
| Apr 19, 2023 | Wednesday | 07:25 | before the open | Mar 31, 2023 | 10-Q · May 4, 2023 | 11 sessions | 8-K |
| Jan 25, 2023 | Wednesday | 07:38 | before the open | Dec 31, 2022 | 10-K · Feb 17, 2023 | 17 sessions | 8-K |
| Oct 19, 2022 | Wednesday | 07:58 | before the open | Sep 30, 2022 | 10-Q · Nov 1, 2022 | 9 sessions | 8-K |
| Jul 20, 2022 | Wednesday | 07:36 | before the open | Jun 30, 2022 | 10-Q · Aug 2, 2022 | 9 sessions | 8-K |
| Apr 20, 2022 | Wednesday | 07:37 | before the open | Mar 31, 2022 | 10-Q · May 3, 2022 | 9 sessions | 8-K |
| Jan 26, 2022 | Wednesday | 07:47 | before the open | Dec 31, 2021 | 10-K · Feb 18, 2022 | 17 sessions | 8-K |
| Oct 20, 2021 | Wednesday | 07:47 | before the open | Sep 30, 2021 | 10-Q · Nov 3, 2021 | 10 sessions | 8-K |
| Jul 22, 2021 | Thursday | 07:22 | before the open | Jun 30, 2021 | 10-Q · Aug 4, 2021 | 9 sessions | 8-K |
The table shows the 20 most recent quarters. All 67 are in the CSV, with the same columns and one row per quarter.
Download all 67 ABT quarters as CSV → Free, no account.
How Abbott Laboratories shares moved on their latest earnings
Over the 8 announcements with prices in this table, ABT rose 3 times and fell 5 times; the median move, ignoring sign, was 3.6%, against 0.5% for SPY over the same windows. The largest, −10%, came with the results of Jan 22, 2026. Reported EPS beat the consensus estimate in 4 of the 4 quarters with an estimate.
| Announcement | Session | Window, close to close | ABT | SPY | EPS actual / expected |
|---|---|---|---|---|---|
| Apr 16, 2026 | before the open | Apr 15, 2026 → Apr 16, 2026 | −6% | +0.2% | 1.15 / 1.15 (+0.3%) |
| Jan 22, 2026 | before the open | Jan 21, 2026 → Jan 22, 2026 | −10% | +0.5% | 1.5 / 1.49 (+0.3%) |
| Oct 15, 2025 | before the open | Oct 14, 2025 → Oct 15, 2025 | −2.9% | +0.4% | 1.3 / 1.3 (0%) |
| Jul 17, 2025 | before the open | Jul 16, 2025 → Jul 17, 2025 | −8.5% | +0.6% | 1.26 / 1.26 (+0.3%) |
| Apr 16, 2025 | before the open | Apr 15, 2025 → Apr 16, 2025 | +2.8% | −2.2% | |
| Jan 22, 2025 | before the open | Jan 21, 2025 → Jan 22, 2025 | +0.8% | +0.6% | |
| Oct 16, 2024 | before the open | Oct 15, 2024 → Oct 16, 2024 | +1.5% | +0.4% | |
| Jul 18, 2024 | before the open | Jul 17, 2024 → Jul 18, 2024 | −4.4% | −0.8% |
ABT window: when it reported before the open or during market hours, from the previous close to that day's. Split-adjusted closes and EPS with its estimate, from Yahoo Finance. It already happened: it does not anticipate the next announcement.
Where each number comes from
From the 8-K with item 2.02 ("Results of Operations and Financial Condition") that Abbott Laboratories filed on EDGAR, the SEC's public database; only those with their 10-Q or 10-K behind them count, so other 8-Ks with the same item (production figures, monthly sales) stay out. The time is converted to New York time using this specific company's stamp convention (its EDGAR stamp arrives in UTC), and it is not assumed: it is derived from the hours in which EDGAR accepts filings.
What this data does not know
- The exact time of the press release: the 8-K reaches EDGAR minutes or hours later, so Abbott Laboratories's median 07:36 is an upper bound. The session says which one the news landed in, not what minute it was said.
- Nothing before Jul 15, 2009: it is Abbott Laboratories's oldest quarter with announcement and report paired in the file.
- What will happen. Every date on the page already happened. Abbott Laboratories reporting before the open 67 quarters in a row does not say the next one will be the same.
- Abbott Laboratories's identity is its SEC CIK (0000001800), not its symbol: symbols get recycled and renamed.
When other Healthcare companies report earnings
- MRNA
- LLY
- INCY
- CAH
- ELV
- SOLV
- BMY
- DXCM
- CVS
- HSIC
- VTRS
- JNJ
- DVA
- UHS
- CI
- BIIB
- VRTX
- REGN
- CNC
- MRK
- EW
- HUM
- MCK
- COR
- AMGN
- WAT
- WST
- TECH
- ABBV
- IDXX
- DGX
- RVTY
- MTD
- A
- ZBH
- ISRG
- TMO
- ALGN
- HCA
- UNH
- COO
- BDX
- VEEV
- MDT
- DHR
- PFE
- LH
- RMD
- IQV
- GEHC
- STE
- PODD
- BSX
- SYK
- BAX
- CRL
- ZTS
- GILD
- MOS
- HD
More on Abbott Laboratories
Abbott Laboratories is in the Healthcare sector. On the model's multifactor score of Oct 21, 2026 it ranks 447 of 464, and 54 of the 55 companies in its sector that score. It is a quantitative model ranking, not a recommendation.
Abbott Laboratories (ABT) analysis page →
All ~500 S&P 500 companies, sorted by when they report →
Guide: 10-K, 10-Q and 8-K · all guides
What is behind these dates
The concepts on this page, explained from scratch in the Academy. Free, no account.
- Guessing next quarter's earnings gives no edgeWhy knowing a quarter's earnings in advance is not enough to make money: what moves the price is the gap against what was expected.
- Supply, demand and price: why it rises and falls constantlyWhat happens to the price on announcement day, and why excellent results can leave the stock falling.
- The three financial statements of a companyWhat is inside the 10-Q and the 10-K whose lag behind the announcement this page measures.
- Point-in-time data and look-ahead biasWhy the date a figure became public matters as much as the figure, which is exactly the distinction behind the two date columns above.
Source: EDGAR, the SEC's public database (forms 8-K, 10-Q and 10-K). Data through Oct 21, 2026. This is a list of public facts and of calculations made on them, not financial advice or a recommendation to buy or sell.